Rosalyn M. Brock, Chairman of the Board, NAACP at 44th NAACP Image Awards Pre-Show Gala Daniel P. O'Day, Chairman and Chief Executive Officer, Gilead Sciences, Inc. Jacqueline K. Barton, PhD, Jacqueline K. Barton, PhD, Professor Emerita,
Gilead Sciences, Inc. - Governance - Board of Directors The Mechanics of Pharma M&A with Devang Bhuva, SVP, Corporate Development at Gilead Sciences Deepening the U.S.-India Commercial Partnership: Make in India Campaign
The U.S. government has given Gilead Sciences substantial funding to develop Covid-19 related products. Here, Donna Meyer 2:30 pm Panel: Make in India Campaign Hon. B.J. Panda Member of Parliament, Biju Janata Dal (BJD) Party Joseph Alhadeff
N. Anthony Coles, MD Chairman & CEO, Onyx Pharmaceuticals Dr. Coles joined Onyx in March 2008 as President and Chief Board of Directors. Albert Bourla of Pfizer and Paul Hudson of Sanofi also assumed new leadership positions on the PhRMA board. "PhRMA and Leadership | Board of Directors | Scientific Advisors | Enliven
Grand Keynote I Daniel O'Day, Gilead Sciences Inc and Rich Karlgaard I TiEcon 2021 Connect17 - Pt. 1 of 2
At "Connect," we explore of how technologies continue to shape our society by focusing on social impact and beneficial use. John C. Martin, Ph.D. Chairman of the Board and Chief Executive Officer. 2024 HBA Woman of the Year Red Carpet Interview with Devi SenGupta
CNBC's Meg Tirrell reports the latest on Gilead's quarterly earnings amid the CEO's announcement he's stepping down. Ample research shows that companies with diverse boards are more innovative and higher performing. Get an inside look at one SAC Spotlight on PPN v6
FBN's Charlie Gasparino with the latest on the CBS investigation into sexual misconduct allegations against CEO Leslie Moonves. The Mechanics of Pharma M&A with Gilead's Devang Bhuta: Bhuta, Gilead's SVP of corporate development, sits down with
AMGEN Ventures and Business Development in Los Angeles In this episode, Mark talks with Chris Garabedian, Chairman and CEO of Xontogeny, which he founded in 2016 to support multiple
Connect17 - Pt. 2 of 2 Gilead Sciences, Inc. - Gilead Sciences Announces 2.6 Percent
Gilead CEO John Martin, PhD Promising Coronavirus Treatment On The Way? Digital Press Briefing: First Lenacapavir Delivery in Africa
Keys to the Boardroom, Hosted by Gilead #BEWPS Gilead Sciences CEO John Martin, Ph.D., on HIV Treatment Innovation & Healthcare Reform Corporate Leadership Roundtable - June 2, 2021
Women comprise 80% of the healthcare workforce but only about 20% of the leadership positions across healthcare industries. Cabaletta Bio Appoints Global Commercial Leader Shawn Box CEO Aaron Levie joins 'Tech Check' to discuss the Starboard Ventures proxy fight and how it has changed the company.
Committee Composition · Lead Independent Director · Board Chair · Committee Member · Committee Chair. Newsupdate Live #LiveStream #NewsNow | GENEVA - Briefing with ceos of major pharmaceuticals on drugs in the pipeline Part 1 - "Connect17" Series
Daniel O'Day of Gilead Sciences Becomes New Chair of PhRMA Gilead Sciences, and Blueprint Medicines. Sam_Kintz photo. Sam Kintz, MBA. Co-founder, Chief Executive Officer, and Member of the Board of Directors. Joe
Merline Saintil & Robin Washington from Black Women on Boards joins NYSE TV The College of Computer and Mathematical and Natural Sciences in collaboration with the University of Maryland Alumni
How Women Can Become Board Members | Deborah H. Telman, EVP, Corp. Affairs, Gilead Sciences, Inc. Hear from Steve Sitto Associate Director, Global Travel, Meetings, & Events, Gilead Sciences running for GBTA President - Board Welcome to this special mash-up episode, where Shellye Archambeau, Former CEO, MetricStream, Advisor & Author, Deborah H.
In this heartfelt episode of The Patient From Hell, host Samira Daswani talks to Jill Massey, a pharmacist and pharma industry John C Martin and Meg Whitman -- SIEPR Economic Summit 2012 Board and staff of Positive Women's Network USA reflect on our origins, growth, and future after 10 years of power.
Diversity in the C-Suite | Shellye Archambeau, Deb Telman, & Fawn Lopez Donna Meyer #AsksTheCEO of Gilead to Factor in Public Investment into Covid-19 Vaccine Pricing Janice is joined by Robin Washington, Board director of Alphabet, Inc., Honeywell International Inc., Mastercard Foundation,
John Bryant – Former Chairman and CEO of Kellogg's | THE JUNGLE #2 On June 2, we hosted an impactful roundtable discussion with Bay Area leaders to tackle the future of work in an evolving world.
TiEcon 2023 at Santa Clara Convention Center, May 3-5 Day 2 Grand Keynote: Joydeep Ganguly, Senior Vice President, Our Board of Directors oversees the management and risks of our business and is responsible for upholding all our corporate values of integrity, inclusion, In this episode, Julie Gerberding, M.D., Chief Executive Officer for the Foundation for the National Institutes of Health speaks with
How much bioscience business development is really happening in Los Angeles? MODERATOR: Rajit Malhotra, Executive Monkeypox: The Response and What's Next Anthony Welters Joins Gilead Sciences' Board of Directors
James Sapirstein, President and CEO at AzurRx BioPharma Board of Directors and Robert Gallo, MD, The Homer & Martha Gudelsky Distinguished Professor in Medicine, Co-Founder and Director of the Kelsey Louie, CEO of GMHC, presents the 2016 Harlem United Impact Award to Patrick McGovern, Senior Director of Government
Full Show - "Connect17" Series James Sapirstein has served over thirty-five years in the pharmaceutical industry. He is currently the President and CEO of AzurRx Gilead Science | Covid -19 Treatment | CEO Daniel O' Day Speech | Pharma Industry
If you're ready to make an impact on a larger scale, come hear what it takes to serve on a corporate board and how to best Jean-Jacques Bienaimé Chief Executive Officer, BioMarin Mr. Bienaimé joined BioMarin in May 2005 as chief executive officer
TiEcon 2023 Grand Keynote: Joydeep Ganguly, Gilead, & Mohan Giridharadas, LeanTaaS Global Virus Network (GVN) Adds Gilead Sciences to GVN How Women Can Become Board Members | Deb Telman, EVP, Corporate Affairs, Gilead Sciences, Inc.
Board of Directors | Gilead Black Women Leaders: A Competitive Advantage
Grand Keynote at TiEcon 2021 with Gilead Chairman and CEO, Daniel O'Day and Rich Karlgaard conversation about Innovating Session 2: CEO Perspectives othe Economy John C. Martin, PhD, Chairman and CEO, Gilead Sciences and Meg Whitman,
Patient from Hell Ep 79: Navigating Life's Curveballs: From Caregiver to Cancer Survivor Deborah Gordon from the HBA Global Board of Directors interviews Devi SenGupta, Gilead. #HBAWOTY24 #HBAimpact.
PDA West Coast Chapter: 2024 Wrapped John Martin Box CEO Aaron Levie on Starboard proxy fight: Happy overall with relationship
Painting the Art of the Possible with Brad D. Smith The Challenges of Drug Development During COVID-19 The Hamilton Review Ep. 208: John Cogan on the National Debt Crisis Plaguing our Country
Mingle Media TV and Red Carpet Report host, Linda Antwi, were invited to cover the 44th NAACP Image Awards Pre-Gala About This Episode Brad D. Smith, Executive Chairman of the Board of Intuit shares his lessons in leadership and the role of a
Welcome to the Connect17 Conference, Disruptive Technologies that Impact our Communities. Speakers: Kacy Hutchison Vice PWN: 10 Years Fierce
In May 2022, an outbreak of monkeypox, a viral disease, was confirmed. It quickly spread from the United Kingdom to many uesday, November 18, 2025. Digital Press Briefing on breakthrough HIV drug Lenacapavir's Delivery and the America First Global
Wrapped is here. Check out some of our chapter's favorite moments from 2024! PDA WCC Board Officers: Stephanie Lee, Yashu Kelsey Louie presents Impact Award to Patrick McGovern Gilead Sciences Chairman of the Board & CEO John Martin, Ph.D., discusses HIV treatment innovation and the the potential
Gilead Sciences Board of Directors Gillead CEO John Martin on the value CHI delivers for his company and the entire California biomedical community. Video Breif : Gilead Sciences, Inc., is an American biopharmaceutical company headquartered in Foster City, California that
#BreakingNow | Briefing by pharma CEOs on #COVID19 drugs, organised by #IFPMA | 03-09-20 Gilead beats, announces CEO stepping down 2021 WBC Summit Breakout Session: Women's Leadership in Healthcare
The company's Board of Directors has declared an increase of 2.6% in the company's quarterly cash dividend, beginning in the first quarter of 2025. Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Anthony Welters has been appointed to the company's Board of Directors.
The women behind accelerating Black female leaders into board seats, Black Women on Boards, visits the NYSE to talk more Where Courage Stems From as a Minority | Deb Telman, EVP, Corp. Affairs, Gilead Sciences, Inc.
Committee Composition - Gilead Sciences, Inc. - Governance Health Equity & Innovation: A Case Study on Importance of Board Diversity
We are happy to welcome John Cogan, a Senior Fellow at the Hoover Institution, to The Hamilton Review Podcast! Gilead Sciences, Inc. As part of her appointment to the Board of members of our board of directors, specifically Ms. Tomasello, and N. Anthony Coles, MD, Chairman & CEO, Onyx Pharmaceuticals, Inc.
Board of Directors · Daniel O'Day · Jacqueline K. Barton, PhD · Jeffrey A. Bluestone, PhD · Sandra J. Horning, MD · Kelly A. Kramer · Ted W. Love, MD · Harish Manwani. Jean-Jacques Bienaimé, Chief Executive Officer, BioMarin Pharmaceutical Inc.
This coronavirus drug seems promising. Ana Kasparian and John Iadarola discuss on The Young Turks. Keep Hope (and TYT) The Southern AIDS Coalition (SAC) initially launched SPARK! (Southerners Promoting Awareness, Resources & Knowledge) in Welcome to THE JUNGLE – the wild and exciting world of business. The second episode in the COVID-19 series features a
Seeding and Supporting Early-Stage Biotech Companies with Xontogeny CEO Chris Garabedian Hear from Steve Sitto CBS Board weighs future of Leslie Moonves